Stem Cell Therapy with Antioxidants for Cardiovascular Disease

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for cardiovascular disease, including stem cell therapy, do not effectively address oxidative stress, which is detrimental to stem cell efficacy due to their sensitivity to inflammation and oxidative stress, leading to limited therapeutic outcomes.

Innovation Solution

Concurrent administration of antioxidants, such as ascorbic acid and other polyphenols, with stem cell populations like mesenchymal and CD34 cells to enhance the therapeutic effects by reducing oxidative stress and inflammation, thereby improving cardiovascular disease treatment efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If stem cell therapy is administered to treat cardiovascular disease, then therapeutic effects such as angiogenesis and tissue repair are induced, but oxidative stress reduces the efficacy and survival of the administered stem cells

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidoxidative stress
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by administering antioxidants before or concurrently with stem cell therapy to preemptively counteract oxidative stress. This prevents the harmful effects of oxidative stress on stem cells before they can occur, thereby protecting the therapeutic efficacy of the stem cell administration.

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent uses antioxidants as intermediary substances that mediate between the harmful oxidative stress environment and the vulnerable stem cells. The antioxidants act as protective intermediaries that neutralize reactive oxygen species and create a more favorable environment for stem cell survival and function.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If antioxidants are administered to reduce oxidative stress, then stem cell survival and therapeutic efficacy are enhanced, but the treatment protocol becomes more complex

Engineering Contradiction:
Improvestem cell efficacyVSAvoidtreatment protocol
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges two treatments into a single integrated protocol by administering antioxidants and stem cells concurrently or in close sequence. This combination approach consolidates the treatment steps and simplifies the overall protocol while achieving synergistic therapeutic effects.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent employs antioxidants that serve multiple functions: they reduce oxidative stress, enhance stem cell survival, and potentially provide direct therapeutic benefits to cardiovascular tissue. This multi-functionality reduces the need for additional separate treatments, thereby simplifying the overall protocol.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination of stem cells and antioxidants significantly improves cardiovascular disease treatment outcomes by reducing oxidative stress and inflammation, leading to enhanced angiogenesis, tissue repair, and improved cardiac function, as demonstrated in clinical trials.

Implementation Method 1

administering an antioxidant to subject in sufficient amount to enhance the amelioration of cardiovascular disease by said one or more cell populations

Methodology Applied
Scientific EffectOxidative stress reduction: Oxidation

Data Source

PatentUS9205112B2Combination treatment of cardiovascular disease
Publication Date: 2015.12.08 ANGIOSTEM INC

AI summary

Disclosed are methods, compositions of matter and cells for treatment of cardiovascular disease through concurrent inhibition of oxidative stress while administration of a cell therapy. The invention also concerts the modulation of oxidative stress for preferential induction of differentiation while concurrently inhibiting inflammatory processes that decrease efficacy of cellular therapy.